Key facts
- Thalamus’s last known valuation is $191.4M (Jan 2025).
- It has raised $40.9M; the latest was Later Stage VC ($31.4M) in Jan 2025.
- Notable investors include Realm Capital Ventures, LAUNCH Fund, Kapor Capital, 37 Angels, Association of American Medical Colleges — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Thalamus
- ·The full record, as it builds
Funding rounds
No funding rounds for Thalamus are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Thalamus
Developer of an interview management platform designed to provide graduate medical education training programs. The company's platform and mobile application provide a comprehensive online interview reservation and travel experience via a real-time scheduling system, enabling candidates to select interview dates that will minimize travel time during interview season by coordinating interviews within a particular geographical region.
- Sector
- Information Technology
- HQ
- Santa Clara, CA, United States
- Founded
- 2013
- Employees
- 47
- Website
- thalamusgme.com/
- Ownership
- Privately Held (backing)
Thalamus doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Thalamus shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Thalamus in its N-PORT filings yet. We sweep new filings monthly.